Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics, our two core business areas.
The world’s largest biopharmaceutical company, with truly differentiated medicines in cancer, immunology, infectious diseases, ophthalmology and neuroscience.
Twenty-nine medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them antibiotics, anti-malarials and chemotherapy.
Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.